Panayiotis P.
- Country
- Greece
- Department
- Dept of Clin Trials, Haemat Clinic&BMT Unit, Med School, National&Kapodistrian Univ of Athens
Research Overview
- An Extension Study of Venetoclax for Subjects Who Have Completed a Prior Venetoclax Clinical Trial
- Phase 3 Randomized Study of Tafasitamab, Lenalidomide, and Rituximab in Relapsed/Refractory Follicular and Marginal Zone Lymphoma
- Efficacy and Safety Evaluation of Selinexor and Ruxolitinib in Treatment-Naïve Myelofibrosis Patients: A Phase 1/3 Clinical Trial
Data & Insights
Has run more than one trial at 175 of 344 partner sites.
Specializations
Myeloid Disorders
The investigator specializes in treating various myeloid conditions, with particular emphasis on acute myeloid leukemia (AML) and chronic myeloid leukemia (CML). Their research encompasses both newly diagnosed cases and relapsed/refractory disease states.
- Primary and Secondary Myelofibrosis
- IDH1-mutant AML
- CML in Chronic Phase
The investigator explores innovative therapeutic approaches including targeted therapies and combination treatments for myeloid malignancies.
Lymphoid Malignancies
Their expertise extends to various lymphoid disorders, with significant focus on follicular lymphoma and mantle cell lymphoma. The investigator studies novel therapeutic combinations and maintenance strategies.
- B-cell Non-Hodgkin's Lymphoma
- Marginal Zone Lymphoma
- Chronic Lymphocytic Leukemia
The research encompasses both treatment-naïve patients and those with relapsed/refractory disease.
Rare Hematologic Conditions
The investigator addresses uncommon blood disorders, including thrombotic thrombocytopenic purpura and paroxysmal nocturnal hemoglobinuria. Their work involves evaluating novel therapeutic approaches for these challenging conditions.
- Immune-mediated TTP
- Complement-mediated disorders
- Moderate Thrombocytopenia
The focus includes developing treatments for patients with limited therapeutic options.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.